These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37745375)

  • 1. Complete substitution with modified nucleotides suppresses the early interferon response and increases the potency of self-amplifying RNA.
    McGee JE; Kirsch JR; Kenney D; Chavez E; Shih TY; Douam F; Wong WW; Grinstaff MW
    bioRxiv; 2023 Sep; ():. PubMed ID: 37745375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete substitution with modified nucleotides in self-amplifying RNA suppresses the interferon response and increases potency.
    McGee JE; Kirsch JR; Kenney D; Cerbo F; Chavez EC; Shih TY; Douam F; Wong WW; Grinstaff MW
    Nat Biotechnol; 2024 Jul; ():. PubMed ID: 38977924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation of 5 methylcytidine alleviates innate immune response to self-amplifying RNA vaccine.
    Komori M; Morey AL; Quiñones-Molina AA; Fofana J; Romero L; Peters E; Matsuda K; Gummuluru S; Smith JF; Akahata W; Akiyama H
    bioRxiv; 2023 Nov; ():. PubMed ID: 37961509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate Inhibiting Proteins Enhance Expression and Immunogenicity of Self-Amplifying RNA.
    Blakney AK; McKay PF; Bouton CR; Hu K; Samnuan K; Shattock RJ
    Mol Ther; 2021 Mar; 29(3):1174-1185. PubMed ID: 33352107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccines.
    Elliott T; Cheeseman HM; Evans AB; Day S; McFarlane LR; O'Hara J; Kalyan M; Amini F; Cole T; Winston A; Fidler S; Pollock KM; Harker JA; Shattock RJ
    PLoS Pathog; 2022 Oct; 18(10):e1010885. PubMed ID: 36194628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyplex nanomicelle delivery of self-amplifying RNA vaccine.
    Chang YH; Lin MW; Chien MC; Ke GM; Wu IE; Lin RL; Lin CY; Hu YC
    J Control Release; 2021 Oct; 338():694-704. PubMed ID: 34509585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccines.
    Blakney AK; McKay PF; Hu K; Samnuan K; Jain N; Brown A; Thomas A; Rogers P; Polra K; Sallah H; Yeow J; Zhu Y; Stevens MM; Geall A; Shattock RJ
    J Control Release; 2021 Oct; 338():201-210. PubMed ID: 34418521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cationic adjuvant formulation particle type, fluidity and immunomodulators on delivery and immunogenicity of saRNA.
    Blakney AK; McKay PF; Christensen D; Yus BI; Aldon Y; Follmann F; Shattock RJ
    J Control Release; 2019 Jun; 304():65-74. PubMed ID: 31071377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient
    Opsomer L; Jana S; Mertens I; Cui X; Hoogenboom R; Sanders NN
    J Mater Chem B; 2024 Apr; 12(16):3927-3946. PubMed ID: 38563779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of In Vivo Expression of Genes Delivered by Self-Amplifying RNA Using Vaccinia Virus Immune Evasion Proteins.
    Beissert T; Koste L; Perkovic M; Walzer KC; Erbar S; Selmi A; Diken M; Kreiter S; Türeci Ö; Sahin U
    Hum Gene Ther; 2017 Dec; 28(12):1138-1146. PubMed ID: 28877647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-Amplifying RNA: A Second Revolution of mRNA Vaccines against COVID-19.
    Silva-Pilipich N; Beloki U; Salaberry L; Smerdou C
    Vaccines (Basel); 2024 Mar; 12(3):. PubMed ID: 38543952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Big Is Beautiful: Enhanced saRNA Delivery and Immunogenicity by a Higher Molecular Weight, Bioreducible, Cationic Polymer.
    Blakney AK; Zhu Y; McKay PF; Bouton CR; Yeow J; Tang J; Hu K; Samnuan K; Grigsby CL; Shattock RJ; Stevens MM
    ACS Nano; 2020 May; 14(5):5711-5727. PubMed ID: 32267667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of in vitro transcription conditions on yield of high quality messenger and self-amplifying RNA.
    Popova PG; Lagace MA; Tang G; Blakney AK
    Eur J Pharm Biopharm; 2024 May; 198():114247. PubMed ID: 38462138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a self-amplifying mRNA reporter vaccine in explant models of broiler chickens.
    Snoeck J; Chiers K; Tam Y; Sanders NN; Garmyn A
    Poult Sci; 2023 Nov; 102(11):103078. PubMed ID: 37801866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity.
    McCafferty S; Haque AKMA; Vandierendonck A; Weidensee B; Plovyt M; Stuchlíková M; François N; Valembois S; Heyndrickx L; Michiels J; Ariën KK; Vandekerckhove L; Abdelnabi R; Foo CS; Neyts J; Sahu I; Sanders NN
    Mol Ther; 2022 Sep; 30(9):2968-2983. PubMed ID: 35450821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production, Characterization, and Assessment of Permanently Cationic and Ionizable Lipid Nanoparticles for Use in the Delivery of Self-Amplifying RNA Vaccines.
    Kairuz D; Samudh N; Ely A; Arbuthnot P; Bloom K
    Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evaluation of novel oral vaccines based on self-amplifying RNA lipid nanparticles (saRNA LNPs), saRNA transfected Lactobacillus plantarum LNPs, and saRNA transfected Lactobacillus plantarum to neutralize SARS-CoV-2 variants alpha and delta.
    Keikha R; Hashemi-Shahri SM; Jebali A
    Sci Rep; 2021 Oct; 11(1):21308. PubMed ID: 34716391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency.
    Anderluzzi G; Lou G; Woods S; Schmidt ST; Gallorini S; Brazzoli M; Johnson R; Roberts CW; O'Hagan DT; Baudner BC; Perrie Y
    J Control Release; 2022 Feb; 342():388-399. PubMed ID: 34896446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability.
    Voigt EA; Gerhardt A; Hanson D; Jennewein MF; Battisti P; Reed S; Singh J; Mohamath R; Bakken J; Beaver S; Press C; Soon-Shiong P; Paddon CJ; Fox CB; Casper C
    NPJ Vaccines; 2022 Nov; 7(1):136. PubMed ID: 36323666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Trans-amplifying RNA Vaccine Strategy for Induction of Potent Protective Immunity.
    Beissert T; Perkovic M; Vogel A; Erbar S; Walzer KC; Hempel T; Brill S; Haefner E; Becker R; Türeci Ö; Sahin U
    Mol Ther; 2020 Jan; 28(1):119-128. PubMed ID: 31624015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.